Provided by Tiger Trade Technology Pte. Ltd.

LandBridge Co. LLC

83.79
+3.023.74%
Post-market: 83.790.00000.00%19:30 EDT
Volume:205.16K
Turnover:17.04M
Market Cap:6.46B
PE:74.15
High:83.96
Open:80.41
Low:80.41
Close:80.77
52wk High:91.69
52wk Low:43.75
Shares:77.09M
Float Shares:28.15M
Volume Ratio:0.86
T/O Rate:0.73%
Dividend:0.46
Dividend Rate:0.55%
EPS(TTM):1.13
EPS(LYR):0.9358
ROE:11.52%
ROA:7.07%
PB:18.17
PE(LYR):89.54

Loading ...

LandBridge Q2 Net Income Rises 68% Year-over-Year to $31 Million; Revenue Increases 41% Year-over-Year to $66.8 Million

Reuters
·
Aug 06

LandBridge Q2 Revenue Rises 41%, Beats Expectations

Reuters
·
Aug 06

LandBridge Q2 Sales $66.840M Beat $60.117M Estimate

Benzinga Earnings
·
Aug 06

LandBridge Co LLC Q2 Free Cash Flow USD 40.2 Million

Reuters
·
Aug 06

Landbridge Co Llc Q2 Free Cash Flow USD 40.2 Million

THOMSON REUTERS
·
Aug 06

Landbridge Co Llc Q2 Net Income USD 31 Million

THOMSON REUTERS
·
Aug 06

Landbridge Co Llc Q2 Adjusted Ebitda Margin 89%

THOMSON REUTERS
·
Aug 06

Press Release: LandBridge Announces Second Quarter 2026 Results

Dow Jones
·
Aug 06

LandBridge Co LLC Expected to Post Earnings of 44 Cents a Share - Earnings Preview

Reuters
·
Aug 04

LB Pharmaceuticals Price Target Maintained with a $45.00/Share by HC Wainwright & Co.

Dow Jones
·
Aug 03

Earning Preview: LandBridge Co. LLC revenue is expected to increase by 23.39%, and institutional views are optimistic

Earnings Agent
·
Jul 29

LandBridge and WaterBridge Stocks are Setting up for Gains

Dow Jones
·
Jul 28

LB Pharmaceuticals: Buy Rating Reaffirmed on LB-102 Clinical Momentum and Regulatory Progress; $45 Price Target Maintained

TIPRANKS
·
Jul 23

Landbridge is Maintained at Neutral by Piper Sandler

Dow Jones
·
Jul 22

LB Pharmaceuticals Initiated at Outperform by BMO Capital

Dow Jones
·
Jul 21

Landbridge Schedules Second-quarter Earnings Release, Conference Call

Reuters
·
Jul 14

Press Release: LB Pharmaceuticals Reports Inducement Grant to New Employee Under NASDAQ Listing Rule 5635(c)(4)

Dow Jones
·
Jul 11

LB Pharmaceuticals Initiated at Outperform by Wolfe Research

Dow Jones
·
Jul 07

LandBridge Company LLC Class A (LB) Receives a Buy from Wells Fargo

TIPRANKS
·
Jul 04

Press Release: LB Pharmaceuticals Appoints Christopher Zergebel as Senior Vice President, Clinical Operations

Dow Jones
·
Jun 30